Contact Us: 1-518-583-0095 
We’re Hiring… Join Our Team!
Congratulations to Wells Messersmith, MD, Director of Criterium’s Academic GI Cancer Consortium (AGICC) on his appointment to the National Cancer Institute’s Board of Scientific Advisors.
Continue reading
Dr. Deirdre Cohen and Dr. Robert Lentz, principal investigators with the Academic GI Cancer Consortium, attended the ASCO 2024 Annual Conference and shared valuable insights and progress from their innovative research model and clinical trials.
Continue reading
Dr. Thomas Flaig of the University of Colorado and Director of the Academic Urology Research Investigators Consortium (AURIC) discusses recent developments in bladder cancer treatment, including immune checkpoint inhibitors.
Continue readingDr. Thomas Flaig of the University of Colorado and Director of the Academic Urology Research Investigators Consortium (AURIC) discusses how antibody-drug conjugates are used in the treatment of advanced urothelial cancer.
Continue reading
Learn more about D. Ross Camidge, MD, PhD, University of Colorado, Director of the Academic Thoracic Oncology Medical Investigators’ Consortium (ATOMIC), who was honored by a colleague for the 2023 Healio Honors in Medical Oncology.
Continue reading
Dr. Matthew Milowsky joins Sam Chang in a discussion on the patient-reported outcomes from Cohort K of the EV-103 Phase 1b/2 study which analyzed the impact of enfortumab vedotin (EV) alone or combined with pembrolizumab.
Continue reading
Dr. Camidge received the organization’s Daniel C. Ihde Lectureship Award for Medical Oncology.
Continue reading
Dr. Peter Kabos, MD, Associate Professor, Division of Medical Oncology and Dr. D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology were recently honored by the University of Colorado’s Division of Medical Oncology.
Continue readingATOMIC (Academic Thoracic Oncology Medical Investigators Consortium), met at the IASLC 2023 Targeted Therapies of Lung Cancer symposium in February in Santa Monica.
Continue readingATOMIC Director Ross Camidge MD, PhD, draws out novel opinions across the field of thoracic oncology from a panel of international experts discussing their favorite ESMO abstracts from 2022.
Continue reading